A new study has identified three genetic changes in East Asian women linked to an increased risk of breast cancer.
Breast cancer screening is once again controversial. In this editorial, the author discusses new research demonstrating the effectiveness of an MRI imaging technique called first postcontrast subtracted T1-weighted image (FAST).
What is the preferred delivery protocol for breast cancer adjuvant bisphosphonates?
A study of people who were adopted identified genetics as the dominant risk factor in familial breast, prostate, and colorectal cancers.
Breast cancer screening costs for Medicare patients skyrocketed between 2001 and 2009, but the increase did not lead to earlier detection of new breast cancer cases, according to a study.
A new study suggests a safe and effective role for natural steroid hormones in treating postmenopausal breast cancer, with fewer detrimental side effects and improved health profile than with standard antihormone therapies.
A simple blood test is currently in development that could help predict the likelihood of a woman developing breast cancer, even in the absence of a high-risk BRCA1 gene mutation, according to new research.
Researchers have identified genes that may help predict whether a patient with estrogen receptor (ER)-positive breast cancer is likely to benefit from tamoxifen therapy, according to a study.
Circulating tumor cells captured with a microchip-based device can be cultured to establish cell lines for genetic analysis and drug testing.
Current studies indicate that the levels of parabens used in cosmetics are safe (typical levels are 0.1% to 0.3%); however, many believe a relationship to cancer exists, particularly breast cancer. The furor came about after a 2004 study reported finding parabens in the breast tissue of 20 women.
New findings paint a relatively optimistic picture of women's chances of surviving a subset of breast cancers that have spread to the chest wall or skin, but not beyond.
The era of personalized medicine for breast cancer may be just around the corner, thanks to recent advances by USC Stem Cell researcher Min Yu and scientists at Massachusetts General Hospital and Harvard Medical School.
Researchers have created a microchip device that can capture circulating tumor cells, in order to track ongoing genetic mutation within a tumor.
Using an innovative tool that captures heretofore hidden ways that cells are regulated, scientists have identified a protein that makes breast cancer cells more likely to metastasize.
Although use of newer technologies and costs associated with breast cancer screening have increased, no change in stage at diagnosis has been observed in Medicare beneficiaries.
A gel containing the drug tamoxifen and applied to the skin was as effective as the pill form in reducing the growth of breast cancer cells in women with noninvasive cancer.
In the 30 years since mammography was introduced, late-stage breast cancer incidence has decreased by 37%, according to a new study. The analysis, from the University of Michigan Comprehensive Cancer Center in Ann Arbor, takes into account an observed underlying trend of increased breast cancer incidence present since the 1940s
New findings from Fox Chase Cancer Center paint a relatively optimistic picture of women's chances of surviving a subset of breast cancers that have spread to the chest wall or skin.
A microchip-based device developed at the Massachusetts General Hospital (MGH) Center for Engineering in Medicine and the MGH Cancer Center can capture circulating tumor cells (CTCs). The CTCs can then be cultured to establish cell lines for genetic analysis and drug testing.
A compound initially developed as a treatment for high cholesterol not only halts the progression of breast cancer, but also can kill cancer cells.
The presence of hyperlipidemia has been linked to 1.64-fold increased risk of breast cancer.
Barriers to obtaining gene expression profiling tests increased their perceived importance among patients with early breast cancer (estrogen-receptor positive [ER+], human epidermal growth-factor receptor 2 negative [HER2-], and node negative) who were deciding whether to have chemotherapy after surgery, according to a new study from Canada.
Study findings from Fox Chase Cancer Center offer relatively optimistic news for women with breast cancer whose disease has spread to the chest wall or skin, but not beyond.
A new study has found that the levonorgestrel-releasing intrauterine system, or progesterone-releasing IUD, may be associated with a higher than expected incidence of breast cancer.
A series of simple telephone calls can make a profound difference in helping women with breast cancer to meet their treatment goals for weight loss.
A recent study of HER2 testing in a large cohort of women with breast cancer found important limitations in testing methods.
The fight against breast cancer is never-ending, but Virginia Tech researchers have found additional diagnostic markers that may aid clinicians to better forecast and prevent the disease.
The more sugary drinks a woman consumes, the greater her risk for breast cancer, a study has found.
Massachusetts legislators introduced a bill that requires doctors to tell patients when a mammogram reveals that the woman has breast dense tissue.
The use of new technique, which includes four approaches, could reduce unnecessary breast biopsies.
High cholesterol levels may increase a woman's risk of developing breast cancer, a large new British study reports.
Many patients older than 65 years with localized breast cancer are eligible for adjuvant hormonal therapy, but little is known about why patients start and stop treatment.
A new systematic review shows that treatment with the breast cancer drug trastuzumab is associated with prolonged survival in women with advanced breast cancer, but the risk of developing heart problems also increases.
In a comparison of data from 2001-2002 and 2008-2009, the use of screening mammography for Medicare-enrolled women without a history of breast cancer was consistent, at approximately 42%. However, the increase in use of more expensive digital mammography technology has resulted in higher costs ($115 vs $73 per mammogram).
New research presents another cause for concern in regard to the chemical bisphenol A (BPA). The study is the first to examine what impact BPA has on the DNA of mammary glands as they age.
Medicare's mammography costs increased by almost 50% over a 7-year period while the breast cancer detection rate and stage at diagnosis did not change, according to a study.
A study from the University of Texas MD Anderson Cancer Center reveals a disparity in use of sentinel lymph node biopsy between black and white women.
Imaging breast tumors using four approaches together can better distinguish between malignant breast tumors and those that are benign, compared with imaging using fewer approaches.
The antimalarial drug hydroxychloroquine (HCQ) reverses resistance to tamoxifen in mice, according to investigators.
Scientists have discovered that a gene previously linked to leukaemia could provide an urgently needed target for the development of drugs to treat patients with 'triple negative' breast cancer.
Compared with digital mammography alone, the combination of digital mammography and tomosynthesis increases cancer detection and reduces false-positive results, according to research.
What is the best approach to learning more about the field of Radiation Oncology?
Since mammography was introduced late-stage breast cancer incidence has decreased by 37%, according to a new study
African-American women frequently present with biologically less favorable subtypes of breast cancer, according to a research study.
A study has revealed that the gene Metadherin—which is implicated in promoting the spread of breast cancer tumors—only stimulates tumor growth when the protein made by the gene interacts with a second protein.
A recent innovation in breast cancer biomarkers seeks to visualize the HER3 receptor, which could mean more comprehensive breast cancer imaging and potential treatments.
Although they experienced classic symptoms of post-surgical lymphedema, many breast patients didn't recognize the condition as related to treatment.
Patients with advanced breast cancer that may have spread to their lymph nodes could benefit from a more robust dose of a molecular imaging agent when undergoing lymphoscintigraphy.
Majority of BRCA mutation carriers opted for different surgery than initially planned by surgeon.
Reducing carbohydrate intake could reduce the risk of breast cancer recurrence among women whose tumor tissue is positive for the insulin-like growth factor-1 (IGF1) receptor, according to a new study.
A chemical commonly used in plastics, appears to increase the proliferation of breast cancer cells, according to Duke Medicine researchers.
Among postmenopausal women receiving letrozole as adjuvant therapy for breast cancer, a telephone-based weight loss intervention was effective in promoting weight loss.
Personalized dietary recommendations based on molecular characteristics of primary tumor tissue may be an effective strategy for breast cancer survivors, according to research.
In women with advanced (or metastatic) breast cancer, treatment with the breast cancer drug trastuzumab is associated with prolonged survival but also increases the risk of developing heart problems
Initial results indicate that annual magnetic resonance imaging (MRI) and digital mammography can form an effective screening program for women at high risk of breast cancer, according to research.
A test of tumor microenvironment of metastasis (TMEM) predicted risk of distant metastasis in estrogen receptor-positive and HER2-negative breast cancer, according to a new study.
In the latest major study to consider whether the dangers of mammograms outweigh the benefits, experts say the tests can reduce the chances of dying from breast cancer by nearly 30 percent.
A documentary film showcasing the stories of local women who survived breast cancer may help educate African American women in breast cancer risks and early treatment.
A study evaluating the effectiveness of aromatherapy as a complementary/alternative modality for reducing anxiety in women undergoing CNB was presented at the Oncology Nursing Society 39th Annual Congress.
Sexual health workshops increased nurse knowledge and confidence, allowing nurses to address sexual concerns of breast cancer survivors.
Four new genes have been added to the growing list of those known to cause increased breast cancer risk when mutated.
To better understand breast cancer surgery trends in Canada, researchers reviewed data from the Canadian Institute for Health (CHI) on 57,840 women who underwent breast cancer surgery between 2007 and 2010.
Women with a specific gene mutation have a higher risk of dying from a type of breast cancer, according to a study that raised prospects of targeted drugs.
When women undergo MRIs to check for breast cancer, the scans sometimes reveal suspicious masses elsewhere in the body, which can generate a lot of anxiety and require more testing.
A research group's findings demonstrate a role for risk profiling in the interpretation of mammograms. The new approach takes into account a woman's health risk profile, which may reduce both the number of missed cancers and false positives.
Risk could be reduced by substitution of other legumes or poultry for red meat.
There appears to have been a decrease in late-stage breast cancer in the mammography era, according to a study published online.
Concerned about the associations between obesity, diabetes, and cancer risk, researchers examined the links between carbohydrate intake and breast cancer risk.
Except for frail patients, most participants in a large study complied with their oncologists' recommendations to treat their estrogen-positive breast cancer with hormone therapy.
Many older breast cancer patients with localized disease are taking drug treatments to prevent their cancer from returning, a new study finds. The research, covering a 7-year period, included more than 1,000 women, age 65 to 91 years, across the United States who had estrogen-positive breast cancer that had not spread.
Only 35 percent of women meet current physical activity guidelines after breast cancer diagnosis, with African-American women less likely to meet guidelines, according to a study published online.
In two studies, a higher risk of breast cancer seen for women with more moles.
An inexpensive malaria drug could be the answer for some women who are not responding to their cancer treatment, according to a promising but preliminary animal study.
The driving forces in the evolution of health care are the aging US population, an increasing cultural awareness of health and cancer, and recognition of patients as consumers.
The largest clinical study to evaluate breast cancer screening of female survivors of childhood Hodgkin lymphoma, showed that MRI detected invasive breast tumors at very early stages, when cure rates are expected to be excellent.
Promoting lymph flow and optimizing BMI after breast cancer surgery had a 97% success rate for patients in the program 1 year after surgery, according to a new study.
Needle biopsy appears to be underused in patients with breast cancer, according to a study published online June 9 in the Journal of Clinical Oncology.
Three months of yoga practice is enough to reduce inflammation and fatigue in breast cancer survivors, a study has found.
Although most women are aware of breast cancer and know someone who has battled the disease, hearing the words "You have cancer" can be a traumatic experience. They can be easily overwhelmed by the information presented during a consult with their doctor. This new book can help them manage their cancer care.
Using combination of exercise and diet to lose weight can significantly cut the risk of breast cancer.
For patients with HER2+ breast cancer, distant invasive recurrence is low for T1a tumors and is higher for T1b tumors.
Scientists from the Florida campus of The Scripps Research Institute have found new targets for potential intervention in breast cancer.
For patients undergoing chemotherapy for breast cancer, cognitive complaints after treatment may be associated with changes in brain activity, according to a study.
Approximately 70% of women who have both breasts removed following a breast cancer diagnosis do so despite a very low risk of facing cancer in the healthy breast, new research has found.
In patients with triple-negative breast cancer (TNBC) who are BRCA1/2 mutation carriers, pathologic complete response (pCR) is not a surrogate for relapse-free survival, in contrast to those with non-BRCA mutations.
Tea drinkers could have less of a breast cancer risk as it increases the functions of blood vessels, says a new research.
Occupational exposure to solvents before first full-term birth may be associated with an increased risk of breast cancer in certain settings, according to a study.
HER2-positive breast cancer typically develops resistance to Herceptin within several years. researchers have found a means of inhibiting another protein whose expression is also upregulated in HER2-positive breast cancer.
For premenopausal women with hormone receptor-negative early breast cancer treated with chemotherapy, goserelin can preserve ovarian function, according to a study presented at the annual ASCO meeting.
Although large genetic testing panels promise to uncover clues about patients' DNA, a team of researchers has found that those powerful tests tend to produce more questions than they answer.
Results from an open label clinical study evaluating the drug enobosarm shows promise for women with metastatic, androgen receptor positive, estrogen receptor positive breast cancer.
Women that suffered from childhood Hodgkin lymphoma should seek magnetic resonance imaging (MRI) screening for early breast cancer detection.
Adding lapatinib to adjuvant trastuzumab for early-stage HER2-positive breast cancer does not improve patients' disease-free survival rates.
Adjuvant treatment with the aromatase inhibitor (AI) exemestane plus ovarian function suppression significantly reduced risk of disease recurrence in premenopausal women with hormone receptor (HR)-positive early breast cancer compared with tamoxifen plus ovarian function suppression (OFS), representing "a new treatment option for premenopausal women."
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|